339 results on '"Darmani, Nissar A."'
Search Results
2. An ontogenic study of receptor mechanisms by which acute administration of low-doses of methamphetamine suppresses DOI-induced 5-HT2A-receptor mediated head-twitch response in mice
3. Signal transduction pathways involved in dopamine D2 receptor-evoked emesis in the least shrew (Cryptotis parva)
4. Central and peripheral emetic loci contribute to vomiting evoked by the Akt inhibitor MK-2206 in the least shrew model of emesis
5. Ultra-low doses of methamphetamine suppress 5-hydroxytryptophan-induced head-twitch response in mice during aging.
6. Dopamine receptors in emesis: Molecular mechanisms and potential therapeutic function
7. A Comparative Study of the Antiemetic Effects of α2-Adrenergic Receptor Agonists Clonidine and Dexmedetomidine against Diverse Emetogens in the Least Shrew (Cryptotis parva) Model of Emesis
8. Δ9-THC and related cannabinoids suppress substance P- induced neurokinin NK1-receptor-mediated vomiting via activation of cannabinoid CB1 receptor
9. A Comparative Study of the Antiemetic Effects of α 2 -Adrenergic Receptor Agonists Clonidine and Dexmedetomidine against Diverse Emetogens in the Least Shrew (Cryptotis parva) Model of Emesis.
10. Intracellular emetic signaling evoked by the L-type Ca2+ channel agonist FPL64176 in the least shrew (Cryptotis parva)
11. The anti-asthmatic drug pranlukast suppresses the delayed-phase vomiting and reverses intracellular indices of emesis evoked by cisplatin in the least shrew (Cryptotis parva)
12. Ultra-low doses of the transient receptor potential vanilloid 1 agonist, resiniferatoxin, prevents vomiting evoked by diverse emetogens in the least shrew (Cryptotis parva)
13. Ca2 + signaling and emesis: Recent progress and new perspectives
14. Thapsigargin-induced activation of Ca2+-CaMKII-ERK in brainstem contributes to substance P release and induction of emesis in the least shrew
15. Role of Calcium in Vomiting
16. RNA sequencing least shrew (Cryptotis parva) brainstem and gut transcripts following administration of a selective substance P neurokinin NK1 receptor agonist and antagonist expands genomics resources for emesis research
17. L-type calcium channels contribute to 5-HT3-receptor-evoked CaMKIIα and ERK activation and induction of emesis in the least shrew (Cryptotis parva)
18. Differential and additive suppressive effects of 5-HT3 (palonosetron)- and NK1 (netupitant)-receptor antagonists on cisplatin-induced vomiting and ERK1/2, PKA and PKC activation
19. Broad-spectrum antiemetic efficacy of the l-type calcium channel blocker amlodipine in the least shrew (Cryptotis parva)
20. Cyclophosphamide causes activation of protein kinase A (PKA) in the brainstem of vomiting least shrews (Cryptotis parva)
21. Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT3 receptor antagonist palonosetron in the least shrew (Cryptotis parva)
22. Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva)
23. Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system
24. Cisplatin causes over-expression of tachykinin NK1 receptors and increases ERK1/2- and PKA‐ phosphorylation during peak immediate- and delayed-phase emesis in the least shrew (Cryptotis parva) brainstem
25. Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva)
26. Evidence for Bell-Shaped Dose-Response Emetic Effects of Temsirolimus and Analogs: The Broad-Spectrum Antiemetic Efficacy of a Large Dose of Temsirolimus Against Diverse Emetogens in the Least Shrew (Cryptotis parva)
27. Pranlukast prevents cysteinyl leukotriene-induced emesis in the least shrew ( Cryptotis parva)
28. Differential temporal changes in brain and gut substance P mRNA expression throughout the time-course of cisplatin-induced vomiting in the least shrew ( Cryptotis parva)
29. Metabolic design in a mammalian model of extreme metabolism, the North American least shrew ( Cryptotis parva )
30. Δ9-Tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew
31. Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew ( Cryptotis parva)
32. The antiemetic interaction of Δ 9-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrew
33. A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: Evidence from the least shrew
34. The Contribution of Phospholipase C in Vomiting in the Least Shrew (Cryptotis Parva) Model of Emesis
35. Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK 1 receptor antagonists
36. Exercise-induced nausea and vomiting: another sign and symptom of pheochromocytoma and paraganglioma
37. Histomorphology and Immunohistochemistry of the Lower Esophageal Sphincter of the Least Shrew (Cryptotis Parva)
38. Metabolic design in a model of extreme mammalian metabolism, the North American least shrew (Cryptotis parva)
39. Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems
40. The Role of Endocannabinoids and Arachidonic Acid Metabolites in Emesis
41. Index
42. Receptor mechanism and antiemetic activity of structurally‐diverse cannabinoids against radiation‐induced emesis in the least shrew
43. A histologically derived stereotaxic atlas and substance P immunohistochemistry in the brain of the least shrew ( Cryptotis parva) support its role as a model organism for behavioral and pharmacological research
44. Preface
45. The 5-HT3 agent N-(3-chlorophenyl)guanidine (MD-354) serves as a discriminative stimulus in rats and displays partial agonist character in a shrew emesis assay
46. Akt‐PI3K signaling pathway is a crucial player in dopamine D 2 receptor‐mediated emesis in least shrews
47. In vitro Antiviral Activity of Neem (Azardirachta indica L.) Bark Extract against Herpes Simplex Virus Type-1 Infection
48. Endocannabinoids and Gastrointestinal Function
49. Ablation of Least Shrew Central Neurokinin NK1 Receptors Reduces GR73632-Induced Vomiting
50. The antiemetic interaction of Δ9-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrew
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.